Publication | Closed Access

Discovery of 4-((4-(4-(3-(2-(2,6-difluorophenyl)-4-oxothiazolidin-3-yl)ureido)-2-fluorophenoxy)-6-methoxyquinolin-7-yl)oxy)-N,N-diethylpiperidine-1-carboxamide as kinase inhibitor for the treatment of colorectal cancer

Medicinal ChemistryKinase InhibitorMedicinePharmacologyColorectal CancerAnti-cancer AgentOncologyRadiation OncologyPharmaceutical ChemistryCancer ResearchDrug Discovery